Esterified Saccharide Compounds TRIZ Cases

Benzene ring glucose derivatives improve target-to-nontarget ratios by resolving trade-offs between preparation simplicity and tumor accumulation.

Butanol extraction isolates Myc factors to resolve the difficulty of studying obligate AM fungi symbiosis mechanisms.

Solvent-free phosphate transesterification with dianhydrohexitols eliminates solid by-product handling and corrosion from chloride release.

Biodegradable sucrose ester cationic lipids deliver genes via electrostatic complexation while reducing cytotoxicity.

Supercritical fluid chromatography extracts rhamnolipids from fermentation broth using temperature and pressure adjustments.

Biphasic liquid-liquid extraction removes chlorine hydride byproducts to prevent N,N-dimethylformamide decomposition during sucralose-6-acetate chlorination.

Beta-modified phosphoric acid precursors overcome the selectivity-efficiency trade-off of conventional inhibitors by irreversibly binding to targeted enzymes.

Glucopyranosyl lipid A monotherapy stimulates protective immune responses in cancer patients.

A glycosylation method using Lewis acid catalysis to prepare alpha-galactosyl ceramides efficiently.

Patsnap Eureka analyzes monosulphate carbohydrate fatty acid esters purified via fractionation to serve as effective vaccine adjuvants.

Acid-catalyzed isomerization of rebaudioside A shifts the exocyclic double bond to an endocyclic position in iso-rebaudioside A.

Carbohydrate esters induce cellulase and amylase production, eliminating catabolic repression to boost yields.

Deuterated nucleoside compounds exhibit potent anti-coronavirus activity through sustained pharmacological concentrations.

Engineered bacteria synthesize fucosylated oligosaccharides via metabolic pathways, replacing costly chemical synthesis with efficient biological production.

Removing tertiary amides via liquid-liquid extraction during quenching to lower energy consumption.

Genetic engineering creates a modified lipopolysaccharide glycoform acting as a molecular decoy to sequester vancomycin and reduce endotoxicity.

Benzamide-derivatized hexosamine analogs inhibit UAP enzyme activity, reducing glucose flux and suppressing disease-promoting glycan production in cancer cells.

Tributanoylated hexosamine analogs inhibit NFκB signaling to reduce inflammatory cytokine expression and restore cartilage homeostasis.

Lewis acid catalysts enable efficient tetrazine synthesis, resolving complex route bottlenecks for live-cell bioorthogonal applications.

Crystallizing LNnT tetrasaccharide in water and methanol yields a stable polymorph, resolving production cost and purification complexity.

Aromatic lipid A mimics replace sugar residues to boost TLR4 binding affinity and immunostimulatory activity.

Fluorinated glucosamine analogs interfere with chondroitin sulfate proteoglycan biosynthesis by targeting the 4-epimerase enzyme.

Glycoside derivatives inhibit SGLT2 to promote renal glucose excretion, addressing hyperglycemia without compromising insulin secretion.

Counter-current vapor contact dehydrates sucrose mixtures in minutes, preventing carbohydrate decomposition and improving yield.

Segmenting the glucosamine disaccharide core with orthogonal protection eliminates structural heterogeneity from natural bacterial extracts.

Adding fucose analogs to culture media inhibits FUT8, reducing core fucosylation and enhancing ADCC activity without genetic engineering.

Phosphine-tin complex enables homogeneous sucrose-6-ester synthesis, resolving low yield and selectivity issues.

Phenol compound-linked pentagalloyl glucose derivatives deliver anti-diabetic and anti-cancer effects without additional additives.

Titanium isopropoxide catalyzes azidotrimethylsilane reaction to crystallize neuraminic acid derivatives.

Chemical synthesis of disaccharide lipid compounds eliminates natural source contaminants, ensuring high purity and consistent biological activity.

Triterpene derivatives bypass adamantane and Tamiflu resistance by blocking viral entry, restoring efficacy against resistant H3N2 and H1N1 strains.

Engineered alpha (1,2) fucosyltransferase catalyzes L-fucose transfer to synthesize purified fucosylated oligosaccharides.

An ammonium N-acetylneuraminate anhydrate crystal raises the melting point to 166°C and solubility to 150 g/L, resolving storage instability.

A nested heating pipe and annular cooling apparatus enable continuous sucrose-6-ester production by integrating distillation and reaction steps.

Segmented micro-reactors accelerate heterogeneous polysaccharide reactions, resolving the trade-off between batch processing speed and operational complexity.

Fluorescent moenomycin probes identify glycosyltransferase inhibitors via competitive binding, overcoming bacterial cell wall penetration barriers.

An orthogonally protected oligosaccharide core enables sequential glycosyl donor attachment to build complex multi-antennary structures.

A one-pot multienzyme system synthesizes UDP-sugars and oligosaccharides using kinases, pyrophosphorylases, and glycosyltransferases.

Tripartite prodrugs with disulfanylalkyl carbonate linkers enhance solubility and permeability, resolving low oral bioavailability.

Acylation of sialic acid aminopyranose derivatives enhances immunogenicity, resolving poor immune response induction in carbohydrate-based anti-tumor vaccines.

Microwave heating drives transesterification of sucrose and fatty acid esters under reduced pressure to yield high-purity monoesters.

Altering the central glycosidic linkage of QS-21 saponins improves chemical stability and reduces toxicity while maintaining immune response stimulation.

N-acetyl glucosamine derivatives overcome low bioavailability of standard treatments by incorporating fatty acid chains to improve therapeutic efficacy.

Alkali metal N-acetylneuraminate anhydrate crystals resolve storage instability and acidity issues through controlled pH crystallization.

Sulfonation introduces sulfonic acid groups to sugar-based materials, resolving the trade-off between water reduction and excessive setting time delays.

Recombinant yeast enzymes synthesize lacto-N-neotetraose from lactose, replacing costly mammalian catalysts.

Metabolites of GLP1R agonists improve glycemic control while reducing side effects like weight gain.

Electron-deficient aryl sulfate diesters introduce sulfation to silylated hydroxyl groups in carbohydrates and peptides.